The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136108 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Carolina Branco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Renal Transplantation, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal. Hauptthemen laut MEDLINE: Multiple Myeloma, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple myeloma (MM) is frequently associated with cytogenetic abnormalities, with high-risk cytogenetics linked to poorer survival. Acute kidney injury (AKI) is common in MM, but its relationship with high-risk cytogenetics remains underexplored. This study aimed to assess the association between high-risk cytogenetics and AKI in newly diagnosed MM patients and to evaluate their impact on overall survival, relapse-free survival, and progression to chronic kidney disease (CKD) in the first two years after diagnosis. We conducted a single-center retrospective cohort study including patients newly diagnosed with MM between 2018 and 2022. We enrolled 122 patients. AKI was observed in 36.9% of patients, rising to 62.3% among those with high-risk cytogenetics. High-risk cytogenetics (OR: 3.32; 95% CI: 1.17–6.40; p = 0.024), CKD (OR: 9.14; 95% CI: 2.92–18.65; p < 0.001), kappa free light chains, hypercalcemia, difference in free light chain (dFLC), and bone marrow plasmocyte percentage were independently associated with AKI. Both AKI (HR: 2.71; 95% CI: 1.18–6.23; p = 0.019) and high-risk cytogenetics (HR: 3.33; 95% CI: 1.13–9.76; p = 0.029) were independently associated with lower overall survival. Among survivors without prior CKD, progression to CKD was higher in those with AKI (30.7% vs. 9.3%; p = 0.041). High-risk cytogenetics were significantly associated with AKI in MM patients. Both factors independently predict worse survival and increased risk of CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Renal Transplantation, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal.
- Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.
- Division of Hematology, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal.
- Gulbenkian Institute for Molecular Medicine (GIMM), 1649-028 Lisbon, Portugal.
ORCID-Profile: Carolina Branco, Joana Vieira
Zitieren
APA
Branco, C., Silva, M., Rodrigues, N., Vieira, J., Forjaz Lacerda, J., & Lopes, J. A. (2025). The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136108
Vancouver
Branco C, Silva M, Rodrigues N, Vieira J, Forjaz Lacerda J, Lopes JA. The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136108
BibTeX
@article{Branco2025,
author = {Branco, Carolina and Silva, Manuel and Rodrigues, Natacha and Vieira, Joana and Forjaz Lacerda, João and Lopes, José António},
title = {The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136108}
}
EUVIMED